The expression of GLS (p < 0.001), LIPT1, FDX1, SLC31A1 (p < 0.01), DLST, CDKN2A, PDHA1, ATP7A, ATP7B, and NFE2L2 (p < 0.05) was different between glioma and adjacent tissues (Figure 1A). This evidence concerns the gene CDKN2A and central nervous system cancer.